Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of 

Articles

The FDA has given its approval to Byooviz (ranibizumab-nuna, SB11, Samsung Bioepis Co Inc and Biogen Inc), a biosimilar referencing Lucentis (ranibizumab, Genentech).

FDA approves first biosimilar product for retinal diseases

Improvements are seen after gene therapy for Leber congenital amaurosis.

Study examines VR orientation, mobility testing for patients with inherited retinal diseases

Videos

Jay Duker, MD, discusses EYP-1901, EyePoint Pharmaceuticals’ sustained-release anti-VEGF drug for the treatment of wet AMD.

New sustained-release anti-VEGF formula proves safe and effective in phase 1 trials

Options facilitate increased durability for patients with retinal degeneration.

Two new retinal surgical procedures for wet AMD: PDS and RGX-314

According to a team of French investigators, every patient hospitalized with severe COVID-19 cases in their study had retinal and choroidal anomalies on indocyanine green angiography and optical coherence tomography images that were possibly related to the virus.

Severe COVID-19 infections associated with retinal, choroidal microvascular lesions

At AAO 2021, Aerie Pharmaceuticals presented the results of their phase 2b clinical trial of AR-15512, a TRPM8 antagonist, for the treatment of dry eye.

Results from phase 2b study of AR-15512 for the treatment of dry eye

The Children’s Vision Equity Alliance was created to improve access in children’s vision and eye health, working to advance equity in children’s vision and eye health through education, policies and partnerships.

Prevent Blindness: National Center for Children’s Vision and Eye Health forges Children’s Vision Equity Alliance

Save the dates for this virtual interactive conference featuring top US ophthalmologists.

 The inaugural EyeCon Meeting 2021 kicks off December 10

Patients can get real-time disease monitoring with self-operated device.

Wet AMD home monitoring systems provide high-quality scans

SD-OCT is providing reproducible, high-quality, registered images to assess the treatment response in macular disease.

The inaugural EyeCon Meeting 2021 kicks off December 10

Wet AMD home monitoring systems provide high-quality scans

Managing diabetic eye disease eased with repeatable, high-quality imaging